The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> April 19, 2012

SAP AG (SAP)

Papandrea, John
John Papandrea, as Senior Vice President of Health Sciences at SAP AG, drives the company’s industry leadership efforts in providing strategic software solutions to health care provider and life sciences organizations around the world. He has more than 23 years of health science industry and related technology experience and has experience providing strategic direction and advice to an array of clients throughout the world. Mr. Papandrea has an interest in the future of medicine, translational and biomedical informatics, disruptive innovation, new service models and how health care convergence can be supported by innovative emerging technologies. Previously, he worked with Deloitte Consulting, Capgemini and Ernst & Young, driving strategic partner relationships and advising clients on the value derived from the use of information technology in health care, particularly in the clinical arena. Mr. Papandrea holds a bachelor’s degree in biomedical science from the University of Technology, Sydney and a master’s degree in health administration from The University of New South Wales, Australia. Profile
TWST: Please tell us about SAP’s offerings in the health care space. Where does the company focus its major products and services it offers within the health care area?

Mr.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy